Dicerna Pharmaceuticals Competitors and Similar CompaniesClear all
Sangamo Therapeutics France's competitors and similar companies include Morphogenesis, Abdera Therapeutics and ImmunityBio.
 Sangamo Therapeutics France Sangamo Therapeutics France (formerly known as TxCell) is a biotechnology company that develops platforms for innovative, personalized T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases with high unmet medical needs. |  Abdera Therapeutics Abdera Therapeutics is a biopharmaceutical company that provides an antibody engineering platform to design and develop precision radiopharmaceuticals for cancer. |  ImmunityBio ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. | ||
Founding Date | Founding Date 2001 | Founding Date 1995 | Founding Date 2020 | Founding Date 2014 |
Type | Type Subsidiary | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Valbonne, FR HQ | Locations Tampa, US HQ | Locations Menlo Park, US HQ Vancouver, CA | Locations Culver City, US HQ San Diego, US Woburn, US |
Employees | Employees 7 | Employees 19 | Employees 723% increase | Employees 16116% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) €2.2m (FY, 2017) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $113.3m (FY, 2025) |
Net income | Net income (€10.9m) (FY, 2017) | Net income N/A | Net income N/A | Net income ($351.5m) (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 16m (about 8 years ago) | Latest funding round $ 110m (over 3 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 71.6m | Total funding raised $ 16m | Total funding raised $ 147.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Morphogenesis
HQ
Tampa, US
Employees
19
Morphogenesis is a clinical stage company specializing in cell and gene therapies.
View companyAbdera Therapeutics
HQ
Menlo Park, US
Employees
72↑ 3% increase
Abdera Therapeutics is a biopharmaceutical company that provides an antibody engineering platform to design and develop precision radiopharmaceuticals for cancer.
View companyImmunityBio
HQ
Culver City, US
Employees
161↑ 16% increase
ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases.
View company